Literature DB >> 30593629

Membrane Fusion Assays for Studying Entry Hepatitis C Virus into Cells.

Solène Denolly1, François-Loïc Cosset2, Natalia Freitas1.   

Abstract

The membrane fusion properties of HCV envelope glycoproteins can be evaluated using several assays. Fusion assays generally require contacts between glycoproteins expressed on a donor membrane, such as those from a cell or a viral particle, and an acceptor membrane that may or may not express cognate viral receptor, such as those from an indicator cell or a liposome. In this chapter, we describe three well-established methods in the field that use either cell surface expression of glycoproteins, HCV pseudoparticles (HCVpp), or cell culture-grown HCV (HCVcc) particles for donor membrane and cells or liposomes as acceptor membrane in which specific components can be included to monitor and quantify fusion. We provide details of cell-cell fusion assay, virus-liposome fusion assay, and finally virus-plasma membrane fusion assay. We also describe inhibitors that can block HCV envelope membrane fusion.

Entities:  

Keywords:  Cell-cell fusion; Fusion; Hepatitis C; Inhibitors; Liposomes; Plasma membrane

Mesh:

Substances:

Year:  2019        PMID: 30593629     DOI: 10.1007/978-1-4939-8976-8_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  A quantitative luciferase-based cell-cell fusion assay to measure four-serotype dengue virus E protein-triggered membrane fusion.

Authors:  Hsiao-Han Lin; Li-Min Huang; Suh-Chin Wu
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.